Follow The Filings

CW Curtiss Wright Corporation

Industrials, filed as CURTISS WRIGHT CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 3 Owners
  • Max 0.1%
  • $2.7M
  • 1 add 1 reduce

In 2026 Q2 Polen Capital Management added to Curtiss Wright, while First Eagle Investment Management trimmed.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Arnold Van Den Berg, Van Den Berg Management I). Not free-float ownership.

  1. Arnold Van Den Berg 0.05%
  2. Polen Capital Management Add 0.01%

Who owns CW

Sorted by value, long equity only, as of 2026 Q2.

History
Polen Capital Management 0.01% Add +74.9% 2,085 $1.6M History
First Eagle Investment Management <0.01% Reduce −17.8% 1,151 $872K History
Arnold Van Den Berg, Van Den Berg Management I 0.05% Hold 327 $248K History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CW's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CW insider trades
  • $149K bought by 1 insider
  • $701K sold by 2 insiders outside a trading plan
  • $15.4M sold by 4 insiders under 10b5-1 plans
  1. Larry D Wyche Director
    Sale
    $60K 100 shares at $596.74 6.6% of stake
    Traded Aug 28 Filed Aug 31
    ↗
  2. John C Watts EVP & Chief Growth Officer
    Sale
    $641K 1,035 shares at $619.46 27% of stake
    Traded Aug 27 Filed Aug 27
    ↗
  3. Jeffrey J. Lyash Director
    Buy
    $149K 209 shares at $711.62 +436% to stake
    Traded Aug 10 Filed Aug 10
    ↗
  4. John C Watts EVP & Chief Growth Officer
    Planned sale
    $154K 200 shares at $770.56 5% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  5. Lynn M Bamford CEO
    Planned sale
    $1.9M 2,500 shares at $758.20 5.2% of stake
    Traded Jun 12 Filed Jun 15
    ↗
  6. Gary A Ogilby Senior VP & Corp Controller
    Planned sale
    $288K 399 shares at $721.95 16% of stake
    Traded Jun 9 Filed Jun 10
    ↗
  7. Lynn M Bamford CEO
    Planned sale
    $1.8M 2,500 shares at $721.72 4.9% of stake
    Traded Jun 9 Filed Jun 10
    ↗
  8. John C Watts EVP & Chief Growth Officer
    Planned sale
    $166K 220 shares at $752.91 5.3% of stake
    Traded May 27 Filed May 27
    ↗
  9. Gary A Ogilby Senior VP & Corp Controller
    Planned sale
    $174K 252 shares at $689.14 8.9% of stake
    Traded Mar 18 Filed Mar 19
    ↗
  10. K Christopher Farkas CFO
    Planned sale
    $872K 1,265 shares at $689.69 23% of stake
    Traded Mar 18 Filed Mar 19
    ↗
  11. K Christopher Farkas CFO
    Planned sale
    $2.2M 3,105 shares at $694.51 42% of stake
    Traded Feb 18 Filed Feb 18
    ↗
  12. Gary A Ogilby Senior VP & Corp Controller
    Planned sale
    $390K 625 shares at $624.32 20% of stake
    Traded Feb 5 Filed Feb 5
    ↗
  13. John C Watts EVP & Chief Growth Officer
    Planned sale
    $173K 288 shares at $600.00 8.3% of stake
    Traded Jan 8 Filed Jan 9
    ↗
  14. John C Watts EVP & Chief Growth Officer
    Planned sale
    $62K 107 shares at $578.84 3% of stake
    Traded Jan 5 Filed Jan 6
    ↗
  15. John C Watts Vice President Strat & Bus Dev
    Planned sale
    $68K 118 shares at $575.00 3.2% of stake
    Traded Dec 23, 2025 Filed Dec 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 13 sales to cover taxes, 7 option exercises, and 3 gifts.

Congress

1 member of Congress traded CW in the last three years: 1 buy and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 22, 2025 filed Aug 13, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jul 10, 2025 filed Aug 13, 2025

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,1.02,2.03,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Period May 7, 2026 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A — Filing Doc

Source: SEC EDGAR submissions, updated 14 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.85B $3.12B $3.5B
Gross profit $1.07B $1.15B $1.3B
Gross margin * 37.5% 37.0% 37.2%
Net income $354.51M $404.98M $484.23M
Net margin * 12.5% 13.0% 13.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.72B $1.85B $2.02B
Total non-current assets * $2.9B $3.14B $3.2B
Total assets $4.62B $4.99B $5.22B
Total current liabilities $0.807B $1.1B $1.41B
Total non-current liabilities * $1.49B $1.44B $1.28B
Total equity $2.33B $2.45B $2.53B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $448.09M $544.28M $643.4M
Cash from investing -$35.52M -$283.31M -$90.12M
Cash from financing -$273.4M -$271.49M -$578.3M
Net change in cash $149.89M -$21.82M -$13.7M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.